{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:30:11Z","timestamp":1792575011798,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.seminoncol.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T01:02:15Z","timestamp":1393635735000},"page":"281-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["Tumor Macroenvironment and Metabolism"],"prefix":"10.1053","volume":"41","author":[{"given":"Wael","family":"Al-Zhoughbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganapathy S.","family":"Paramasivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Till","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Guertl-Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Hoefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2014.02.005_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI115106","article-title":"Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice","volume":"87","author":"Yoneda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib3","doi-asserted-by":"crossref","first-page":"13893","DOI":"10.3390\/ijms140713893","article-title":"Sarcosine as a potential prostate cancer biomarker--a review","volume":"14","author":"Cernei","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2796.2000.00742.x","article-title":"Infections as a major preventable cause of human cancer","volume":"248","author":"Kuper","year":"2000","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2008.11.002","article-title":"Chemokines and the microenvironment in neuroectodermal tumor-host interaction","volume":"19","author":"Somasundaram","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib7","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib8","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib9","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","article-title":"IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis","volume":"17","author":"Jung","year":"2003","journal-title":"FASEB J"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib11","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.144:646-674.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib12","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","article-title":"A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors","volume":"64","author":"Wyckoff","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis: new concept for therapy of solid tumors","volume":"175","author":"Folkman","year":"1972","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","article-title":"The role of triglyceride lipases in cancer associated cachexia","volume":"19","author":"Das","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib16","first-page":"4815","article-title":"Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients","volume":"42","author":"Heber","year":"1982","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib17","first-page":"2590","article-title":"Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer","volume":"48","author":"Fearon","year":"1988","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib18","first-page":"4746","article-title":"Altered leucine metabolism in noncachectic sarcoma patients","volume":"47","author":"Inculet","year":"1987","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib19","first-page":"821","article-title":"Some aspects of nitrogen and energy metabolism in cancerous subjects: a review","volume":"11","author":"Mider","year":"1951","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib20","first-page":"374","article-title":"Potential sources of tumor nitrogen","volume":"10","author":"Sherman","year":"1950","journal-title":"Cancer Res."},{"key":"10.1053\/j.seminoncol.2014.02.005_bib21","first-page":"153","article-title":"Growth of carcinoma implants in fed and fasted rats","volume":"12","author":"Le","year":"1952","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib26","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/cddis.2011.123","article-title":"Cancer metabolism: current perspectives and future directions","volume":"3","author":"Munoz-Pinedo","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib27","first-page":"507","article-title":"Plasma amino acid imbalance in patients with lung and breast cancer","volume":"15","author":"Cascino","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2407-10-690","article-title":"Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study","volume":"10","author":"Maeda","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(19920501)69:9<2343::AID-CNCR2820690924>3.0.CO;2-S","article-title":"Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors","volume":"69","author":"Kubota","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0955-2863(02)00225-5","article-title":"Breast and lung cancer are associated with a decrease in blood cell amino acid content","volume":"14","author":"Proenza","year":"2003","journal-title":"J Nutr Biochem"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib31","doi-asserted-by":"crossref","first-page":"e24143","DOI":"10.1371\/journal.pone.0024143","article-title":"Plasma free amino acid profiling of five types of cancer patients and its application for early detection","volume":"6","author":"Miyagi","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib32","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bbalip.2013.08.001","article-title":"Lipid metabolism in cancer","volume":"1831","author":"Nomura","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib33","first-page":"27","article-title":"Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro","volume":"13","author":"Medes","year":"1953","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib35","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.91.14.6379","article-title":"Fatty acid synthesis: a potential selective target for antineoplastic therapy","volume":"91","author":"Kuhajda","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib37","doi-asserted-by":"crossref","first-page":"22027","DOI":"10.1074\/jbc.M110.126870","article-title":"Decrease in membrane phospholipid unsaturation induces unfolded protein response","volume":"285","author":"Ariyama","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","article-title":"ATP citrate lyase inhibition can suppress tumor cell growth","volume":"8","author":"Hatzivassiliou","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib39","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","article-title":"ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer","volume":"68","author":"Migita","year":"2008","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib40","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-511X-9-15","article-title":"Ceramide and ceramide 1-phosphate in health and disease","volume":"9","author":"Arana","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/187152609788922555","article-title":"The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants","volume":"9","author":"Tsoupras","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib45","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.bbalip.2013.07.008","article-title":"Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids","volume":"1831","author":"Louie","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/labinvest.2009.97","article-title":"Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4","volume":"89","author":"Byon","year":"2009","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib47","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1194\/jlr.M500151-JLR200","article-title":"Free fatty acid release from human breast cancer tissue inhibits cytotoxic T-lymphocyte-mediated killing","volume":"46","author":"Kleinfeld","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib48","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3945\/ajcn.2008.26369","article-title":"Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition","volume":"88","author":"Crowe","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2478\/s11658-008-0014-9","article-title":"Lipid changes occuring in the course of hematological cancers","volume":"13","author":"Kuliszkiewicz-Janus","year":"2008","journal-title":"Cell Mol Biol Lett"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0976-9668.116994","article-title":"Alterations in serum lipid profile patterns in oral cancer","volume":"4","author":"Singh","year":"2013","journal-title":"J Nat Sci Biol Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0019-509X.12341","article-title":"Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions","volume":"41","author":"Patel","year":"2004","journal-title":"Indian J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0009-9120(00)00200-9","article-title":"Role of lipids, lipoproteins and vitamins in women with breast cancer","volume":"34","author":"Ray","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02893044","article-title":"Alterations of serum cholesterol and serum lipoprotein in breast cancer of women","volume":"20","author":"Hasija","year":"2005","journal-title":"Indian J Clin Biochem"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(94)90008-6","article-title":"Alterations of serum lipids and lipoproteins in breast cancer","volume":"82","author":"Kokoglu","year":"1994","journal-title":"Cancer Lett"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s005990070013","article-title":"Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects","volume":"30","author":"Fiorenza","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jnci\/djr008","article-title":"Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study","volume":"103","author":"Benn","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bmj.308.6925.373","article-title":"Assessing possible hazards of reducing serum cholesterol","volume":"308","author":"Law","year":"1994","journal-title":"Bmj"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/SPC.0b013e32834c4a05","article-title":"Cachexia assessment tools","volume":"5","author":"Blum","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib60","first-page":"2327","article-title":"Cachexia, the metabolic component of neoplastic diseases","volume":"37","author":"Costa","year":"1977","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib62","first-page":"401","article-title":"Cytokines in the pathogenesis of cancer cachexia","volume":"6","author":"Argiles","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib63","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","article-title":"Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients","volume":"13","author":"Staal-van den Brekel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.coc.0000221300.72657.e0","article-title":"Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients","volume":"29","author":"Kayacan","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(02)00235-8","article-title":"Cancer cachexia","volume":"85","author":"Fearon","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib67","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib68","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1096\/fasebj.3.8.2721856","article-title":"Anticachectin\/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models","volume":"3","author":"Sherry","year":"1989","journal-title":"FASEB J"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib69","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603360","article-title":"Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice","volume":"95","author":"Bing","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjc.6606083","article-title":"Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients","volume":"104","author":"Mracek","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S0029665109990267","article-title":"New insights into adipose tissue atrophy in cancer cachexia","volume":"68","author":"Bing","year":"2009","journal-title":"Proc Nutr Soc"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib73","first-page":"5062","article-title":"Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats","volume":"44","author":"Lanza-Jacoby","year":"1984","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.beem.2005.07.006","article-title":"Transgenic animal models for the study of adipose tissue biology","volume":"19","author":"Bluher","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib75","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/meta.2000.6740","article-title":"Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects","volume":"49","author":"Zuijdgeest-van Leeuwen","year":"2000","journal-title":"Metabolism"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib76","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00000658-198704000-00005","article-title":"Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding","volume":"205","author":"Shaw","year":"1987","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjc.6600493","article-title":"Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo","volume":"87","author":"Russell","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib78","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbalip.2013.04.012","article-title":"The PPARalpha agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism","volume":"1831","author":"Huang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib79","first-page":"159","article-title":"Pathogenesis of cancer cachexia","volume":"1","author":"Tisdale","year":"2003","journal-title":"J Support Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib80","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.biocel.2004.10.017","article-title":"Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss","volume":"37","author":"Khal","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bjc.6602402","article-title":"NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle","volume":"92","author":"Wyke","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib82","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib84","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6600074","article-title":"Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans","volume":"86","author":"Collins","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib85","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.289.6445.584","article-title":"Protein synthesis in muscle measured in vivo in cachectic patients with cancer","volume":"289","author":"Emery","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib86","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib87","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib88","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib89","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1038\/sj.onc.1206737","article-title":"Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization","volume":"22","author":"Iyengar","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib90","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1349-7006.2008.01053.x","article-title":"Leptin induces functional activation of cyclooxygenase-2 through JAK2\/STAT3, MAPK\/ERK, and PI3K\/AKT pathways in human endometrial cancer cells","volume":"100","author":"Gao","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","article-title":"The growing challenge of obesity and cancer: an inflammatory issue","volume":"1229","author":"Harvey","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib93","first-page":"3","article-title":"Diabetes mellitus and risk of prostate cancer (United States)","volume":"9","author":"Giovannucci","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib94","first-page":"967","article-title":"Diabetes and cancer I: risk, survival, and implications for screening","volume":"23","author":"Onitilo","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib95","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib96","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib97","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis","volume":"57","author":"Deng","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib98","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2407-13-310","article-title":"Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies","volume":"13","author":"Zhu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib99","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/bjc.2012.414","article-title":"Diabetes and breast cancer risk: a meta-analysis","volume":"107","author":"Boyle","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2169\/internalmedicine.52.8276","article-title":"Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan","volume":"52","author":"Chiu","year":"2013","journal-title":"Intern Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib101","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib102","first-page":"1605","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer","volume":"273","author":"Everhart","year":"1995","journal-title":"A meta-analysis. JAMA"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib103","first-page":"837","article-title":"Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis","volume":"22","author":"Ren","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib104","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib106","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1055-9965.EPI-06-0751","article-title":"Diabetes and risk of endometrial cancer: a population-based prospective cohort study","volume":"16","author":"Friberg","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib107","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JME-13-0152","article-title":"A new link between diabetes and cancer: enhanced WNT\/beta-catenin signaling by high glucose","volume":"52","author":"Garcia-Jimenez","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib108","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib109","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib110","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.1174229","article-title":"Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells","volume":"325","author":"Yun","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ccr.2010.01.022","article-title":"A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases","volume":"17","author":"Hirsch","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3121\/cmr.2013.1160","article-title":"Prostate cancer risk in pre-diabetic men: a matched cohort study","volume":"11","author":"Onitilo","year":"2013","journal-title":"Clin Med Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib113","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.juro.2011.07.034","article-title":"External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology","volume":"186","author":"Pichler","year":"2011","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib114","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/01635581.2001.9680613","article-title":"Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer","volume":"41","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/bjc.2013.701","article-title":"Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients","volume":"110","author":"Szkandera","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib116","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/bjc.2013.595","article-title":"Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients","volume":"109","author":"Szkandera","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib117","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib118","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.2013.28","article-title":"Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients","volume":"108","author":"Pichler","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib119","article-title":"The lymphocyte\/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas","author":"Szkandera","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/bjc.2013.443","article-title":"High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients","volume":"109","author":"Pichler","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.semcdb.2012.02.003","article-title":"New aspects of the Warburg effect in cancer cell biology","volume":"23","author":"Bensinger","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib122","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell."},{"key":"10.1053\/j.seminoncol.2014.02.005_bib123","first-page":"91","article-title":"Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells","volume":"7","author":"Park","year":"2001","journal-title":"Int J Mol Med"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib124","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2199-14-27","article-title":"An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2","volume":"14","author":"Terashima","year":"2013","journal-title":"BMC Mol Biol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/01635581.2013.789118","article-title":"Low-glucose conditions of tumor microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells","volume":"65","author":"Navratilova","year":"2013","journal-title":"Nutr Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.nutr.26.061505.111151","article-title":"Cancer-associated cachexia and underlying biological mechanisms","volume":"26","author":"Baracos","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib127","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SPC.0b013e32834bde0e","article-title":"Lipid mobilization in cachexia: mechanisms and mediators","volume":"5","author":"Bing","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fonc.2013.00167","article-title":"Immunosuppressive microenvironment in neuroblastoma","volume":"3","author":"Pistoia","year":"2013","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib129","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00262-013-1466-y","article-title":"Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFbeta1","volume":"62","author":"Xu","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"10.1053\/j.seminoncol.2014.02.005_bib131","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/ijc.28255","article-title":"The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis","volume":"133","author":"Maman","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib132","first-page":"880","article-title":"Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia","volume":"51","author":"Gelin","year":"1991","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib133","first-page":"265","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib134","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjc.6602165","article-title":"Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation","volume":"91","author":"Wyke","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib135","first-page":"5488","article-title":"Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia","volume":"60","author":"Cahlin","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib136","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/carcin\/bgr107","article-title":"Caloric restriction reduces growth of mammary tumors and metastases","volume":"32","author":"De Lorenzo","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib137","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.4161\/cc.25016","article-title":"Caloric restriction augments radiation efficacy in breast cancer","volume":"12","author":"Saleh","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib138","first-page":"1055","article-title":"Potential antitumor effects of statins (review)","volume":"23","author":"Jakobisiak","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib139","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib140","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1476-5381.2009.00465.x","article-title":"Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis","volume":"158","author":"Campia","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib141","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.leu.2402196","article-title":"Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells","volume":"15","author":"Xia","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib142","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/ijo.2011.1273","article-title":"Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression","volume":"40","author":"Spampanato","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2014.02.005_bib143","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","article-title":"An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR-dependent pathway","volume":"1","author":"Guo","year":"2011","journal-title":"Cancer Discov"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:54:12Z","timestamp":1758804852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775414000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":143,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0093775414000463"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.02.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Macroenvironment and Metabolism","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}